Top Markets
#1 Gravity Gravity +75.10%
#2 Galxe Galxe +57.82%
#3 TENDIES TENDIES +36.20%
#4 Railgun Railgun +36.15%
#5 Geodnet Geodnet +24.60%
#6 Fake World Assets Fake World Assets +23.71%
#7 Akedo Akedo +22.61%
#8 Injective Injective +16.93%
#9 Kinetiq Kinetiq +16.68%
#10 Collector Crypt Collector Crypt +16.50%
Coin of the day
Gravity Gravity
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Classement en actions #36
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Prix de l'action
$483.81
Capitalisation boursière
$379.28B
Changement (1 jour)
0.92%
Changement (1 an)
46.65%
Pays
CH
Échange Roche Holding AG (RO)

Catégorie

Healthcare
Ratio P/S pour Roche Holding AG (RO)
Ratio P/S au September 2026 TTM : 4.17
Selon les derniers rapports financiers et le cours de l'action de Roche Holding AG, le ratio cours/ventes actuel (TTM) est 4.17. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Roche Holding AG de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
13.45 222.49%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.55 57.15%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.18 72.19%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
5.39 29.18%
US
Novartis AG Novartis AG
Novartis AG
NOVN.SW
5.52 32.37%
CH